- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01994317
Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion
14 augusti 2015 uppdaterad av: Planned Parenthood League of Massachusetts
This study aims to compare an algorithm for IV sedation dosing to the current standard of care in patients undergoing first trimester surgical abortion.
The primary outcome is subjects' pain score with suction curettage on a 0-100 21-point scale.
Secondary outcomes include pain scores with cervical dilation and 15 minutes post-procedure, subjective pain ratings, incidents of side effects and adverse events, the frequency of additional doses of medication, recovery room time, and physician assessment of and satisfaction with pain control.
Investigators hypothesize that this algorithm will result in improved pain control, decreased frequency of additional medication doses, improved patient and physician satisfaction, without differences in side effects, adverse events or recovery room time.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
196
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02215
- Planned Parenthood
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Kvinna
Beskrivning
Inclusion Criteria:
- Women age 18 or older seeking surgical abortion at Planned Parenthood League of Massachusetts (PPLM)
- Gestational age less than or equal to 13+6, confirmed by ultrasound
- Eligible for surgical abortion according to PPLM protocols
- Eligible for IV sedation per PPLM protocol, and desiring IV sedation for pain management
Exclusion Criteria:
- Choice of local anesthesia for pain control
- Hypersensitivity to midazolam or fentanyl
- Ineligible for IV sedation per PPLM protocol
- Need for cervical ripening with either misoprostol or mechanical priming agent (laminaria/Dilapan)
- Unable or unwilling to complete required study procedures
- Previous participation in the study
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Standard sedation dose
IV sedation dose calculated using current standard of care
|
IV sedation dosing calculated by standard care.
|
Experimentell: Algorithm
IV sedation dose calculated by study algorithm
|
IV sedation dosing calculated by algorithm
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Pain with suction curettage
Tidsram: Measured on Day 1 (day of enrollment), immediately (within one minute) after completion of suction curettage and speculum removal
|
Subjects' pain score with suction curettage on a 0-100 21-point scale
|
Measured on Day 1 (day of enrollment), immediately (within one minute) after completion of suction curettage and speculum removal
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Pain with paracervical block
Tidsram: Measured on Day 1 (day of enrollment), immediately after paracervical block
|
Pain with paracervical block will be measured (a) on a 21-point 0 to 100 scale (in increments of five), and (b) on a subjective scale of "no pain, mild pain, moderate pain or severe pain."
Pain will be measured immediately after paracervical block.
|
Measured on Day 1 (day of enrollment), immediately after paracervical block
|
Pain with cervical dilation
Tidsram: Measured on Day 1 (day of enrollment), immediately after cervical dilation
|
Pain with cervical dilation will be measured (a) on a 21-point 0 to 100 scale (in increments of five), and (b) on a subjective scale of "no pain, mild pain, moderate pain or severe pain."
Pain with cervical dilation will be measured immediately after cervical dilation.
|
Measured on Day 1 (day of enrollment), immediately after cervical dilation
|
Post-operative pain
Tidsram: Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
Post-operative pain will be measured (a) on a 21-point 0 to 100 scale (in increments of five), and (b) on a subjective scale of "no pain, mild pain, moderate pain or severe pain."
Pain will be measured 15 minutes post-operatively when the patient is in the recovery room.
|
Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
Patient satisfaction with pain control
Tidsram: Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
Patients will be asked about their general satisfaction with pain control, what their pain was compared to what they expected, whether they would chose the same pain management strategy again, and whether they would recommend their strategy of pain management to a friend.
|
Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
Side effects
Tidsram: Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
Investigators will assess side effects for all patients, including nausea, vomiting, dizziness, and drowsiness.
|
Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Doses given over the duration of the study
Tidsram: Measured on Day 1 (day of enrollment), intraoperatively
|
To assess whether use of the algorithm changes physician's behavior in the standard care arm, investigators will also examine doses given over the duration of the study, to see if a "learning curve" develops among the physicians based on their experience with the algorithm.
|
Measured on Day 1 (day of enrollment), intraoperatively
|
Physician assessment of pain control
Tidsram: Measured on Day 1 (day of enrollment), post-operatively
|
Investigators will also have the physician assess patients' pain control, whether they felt the dose was appropriate and how easy or difficult it was to determine the patients' doses of pain medication.
|
Measured on Day 1 (day of enrollment), post-operatively
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Samarbetspartners
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 november 2013
Primärt slutförande (Faktisk)
1 juli 2015
Avslutad studie (Faktisk)
1 juli 2015
Studieregistreringsdatum
Först inskickad
1 november 2013
Först inskickad som uppfyllde QC-kriterierna
19 november 2013
Första postat (Uppskatta)
25 november 2013
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
17 augusti 2015
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
14 augusti 2015
Senast verifierad
1 augusti 2015
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- SFPRF7-6
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Graviditet, oplanerad
-
King's College Hospital NHS TrustEuropean Association for the Study of the LiverRekryteringCirros, lever | HELLP syndrom | Intrahepatisk kolestas av graviditet | Graviditetssjukdom | AFLP - Acute Fatty Lever of PregnancyStorbritannien
Kliniska prövningar på Standard care
-
Chunrui LiNanjing IASO Biotechnology Co., LtdRekryteringPlasmacellleukemi | Återfall/refraktärt multipelt myelomKina
-
Xuanwu Hospital, BeijingBioray LaboratoriesHar inte rekryterat ännuMultipel skleros | Neuromyelit Optica Spectrum Disorders | Kronisk inflammatorisk demyeliniserande polyradikuloneuropati | Myasthenia Gravis, generaliseradKina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RekryteringKronisk lymfatisk leukemi | Non-Hodgkin lymfom | Akut lymfatisk leukemiFörenta staterna
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityAvslutadEn fas 1-studie som utvärderar säkerhet och effekt av C-CAR011-behandling hos DLBCL-ämnen (C-CAR011)Refraktärt diffust stort B-cellslymfomKina
-
Zhejiang UniversityCarbiogene Therapeutics Co. Ltd.Har inte rekryterat ännuKlinisk prövning av autologa GPC3 CAR-T-celler (CBG166) terapi för avancerad hepatocellulär karcinomAvancerat hepatocellulärt karcinomKina
-
Nexcella Inc.Har inte rekryterat ännuLätt kedja (AL) amyloidosFörenta staterna
-
Second Affiliated Hospital, School of Medicine,...RekryteringÅterfall och refraktärt B-cellslymfomKina
-
Second Affiliated Hospital, School of Medicine,...RekryteringB-cells non-Hodgkin lymfomKina
-
University of California, San FranciscoIndragenLymfom | Leukemi | Plasmacelldyskrasi
-
Hebei Senlang Biotechnology Inc., Ltd.RekryteringLymfom | Multipelt myelom | Akut lymfoblastisk leukemiKina